On this #WorldArthritisDay, we stand with the larger rheumatic and musculoskeletal disease (RMD) community to advocate for better research, education and patient support. 🔗 Hear more from UCB’s Marie Teil on this year’s theme of “Informed Choices, Better Outcomes” and what it means for women in their childbearing years who seek evidence-based data to better navigate their treatment decisions. https://lnkd.in/gmw9MuAt
About us
UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives. UCB – The Facts With approximately 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work: - Promising pipeline that includes several novel molecules; - 2023 Key Financials: € 5.3 billion global revenue Specialties: Neurology, Immunology
- Website
-
http://www.ucb.com
External link for UCB
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Brussels
- Type
- Privately Held
- Founded
- 1928
- Specialties
- Neurology, Immunology, and Healthcare Innovation Beyond Medicine
Locations
Employees at UCB
Updates
-
For healthcare professionals only. 👏 What a successful Pre-Congress Day at FFN EU 2024! Yesterday, led by co-chairs Prof Kassim Javaid and Mr Andrew Gray, experts from across Europe shared invaluable insights into the development of optimized Fracture Liaison Services (FLS) for patients following a fragility fracture. These discussions have set the stage for ongoing multidisciplinary collaboration to enhance osteoporosis care. Thanks to everyone who joined and contributed to the discussions – let's continue to build stronger, healthier communities! 💪🦴 If you’d like to hear more insights from co-chair Prof Javaid, head over to episode 5 of UCB’s podcast series, Fragility Fractures in Focus. 🎧 Listen to the podcast: https://lnkd.in/gfTSZJgN #osteoporosis #fragilityfractures #FragilityFracturesinFocus #FFN2024
-
As part of the US Field Based team, Joshua’s experience at UCB is a true reflection of our commitment to inclusion, respect, and growth. Every day, he thrives in a culture that blends teamwork and impact seamlessly. Through collaboration and a patient-first mindset, Joshua brings UCB’s values to life—making a real difference for people living with severe diseases. We’re about creating a space where everyone can thrive and contribute to something bigger. Want to see what makes UCB special? Watch Joshua’s story to find out more. #MakeYourMarkForPatients #TeamUCB #PharmaJobs Learn more at UCB Careers: https://brnw.ch/21wNFPT
-
For healthcare professionals only. 🔍 Tackling the Challenges of Fragility Fracture Management and Secondary Fracture Prevention at FFN EU 2024! 🔍 The FFN European Regional Congress 2024 kicks off today and we are thrilled to join top experts who will discuss how to improve the management of patients following a fragility fracture during our pre-congress day session. The session is focused on Fracture Liaison Services (FLS) with the aim of helping optimize post-fracture care by facilitating best practice sharing and equipping multidisciplinary teams with the tools they need to set up their own FLS, through the FLS Academy & Network (FAN). Join us in our commitment to advancing post-fracture care and making a lasting impact on patient outcomes! Register to join the FAN community here: https://brnw.ch/21wNDdh #osteoporosis #fragilityfractures #FragilityFracturesinFocus #FFN2024
-
Meet the co-chairs for the 15th International Immunology Summit 1. Professor Filip Van den Bosch, Head of Clinic and Associate Professor of Rheumatology, Ghent University Hospital, will be joining as our rheumatology chair. 2. Professor Brian Kirby, Consultant Dermatology at St Vincent’s University Hospital and Full Clinical Professor at Charles Institute of Dermatology, University College Dublin, is chairing dermatology. 3. Professor Bene Langdahl, Clinical Professor in the Department of Endocrinology and Internal Medicine at Aarhus University Hospital, is our bone health chair. Join us in welcoming these renowned experts in Prague this November.
-
🌍 We have achieved a significant milestone in our mission to broaden global access to antiseizure medications as one of our solutions is now available for Rwandese people with epilepsy. 🇷🇼💊 Stay tuned for more updates on our commitment to bringing solutions to those who need them most in other underserved communities. Read more: https://brnw.ch/21wNyGn #epilepsy #sustainability #Rwanda
-
At UCB, we’re transforming psoriatic arthritis (PsA) care – by listening to those who live with, and those who research it. PsA advocate Joel Nelson and Adam Prickett, UCB’s Global Medical Lead in PsA, talk about the challenges of psoriatic arthritis. Together, we’re on a mission to halve the rate of disease progression by 2030.
-
Read how UCB's Digital Care Transformation (DCTx) team has fostered close collaborations with innovative startups, accelerating the development of cutting-edge digital healthcare solutions for severe chronic diseases. Learn more about our initiatives and how you can join our Innovation program to create a healthier future for all. https://lnkd.in/d28RdE32 #DigitalCareTransformation #InnovationProgram #UCB
-
The advent of cell and gene therapies is a promising shift in the healthcare landscape, yet it isn't without its unique challenges. From intricate manufacturing phases to regulatory complexities, these obstacles must be navigated for its full potential to be realized. In a recent interview with Clinical Leader, Roger Palframan, Head of US Research UCB, explores these issues - offering insight into how we can overcome them. Read it now: https://lnkd.in/dVvGxRE7 #CellAndGeneTherapy #HealthcareInnovation